Cellular and Molecular Neurobiology

, Volume 8, Issue 2, pp 205–216 | Cite as

Release of3H-dopamine and Analogous monoamines from rat striatal tissue

  • Ross J. Baldessarini
  • Marcella Vogt
Article

Summary

  1. 1.

    The release of previously accumulated3H-dopamine (DA) from minces of striatal tissue prepared from the brains of pargyline-pretreated rats was evaluated by superfusion with a physiological buffer solution in a six-chamber apparatus with silver toroid electrodes to provide electrical field stimuli. The identity of released tritium as3H-DA was demonstrated chromatographically and3H-DA taken up was found in a synaptosomal subcellular fraction.

     
  2. 2.

    Release of3H-DA previously accumulated at 0.3µM was found to be linearly dependent on stimulus intensity between 1 and 10 V (for 60 sec); 5 V was selected as a standard stimulus.

     
  3. 3.

    Release of3H-DA did not occur from minces of rat liver, nor was there release of previously accumulated labeled urea or leucine from striatal tissue by electrical stimulation, 50 mM KCL, or 0.1 mM (+)-amphetamine. When3H-DA was taken up in the presence of cocaine (1 mM) or benztropine (100µM), electrically induced release of3H-DA was markedly reduced, while spontaneous efflux was much less altered.

     
  4. 4.

    Release of3H-DA was also induced by depolarizing concentrations of K+, as well as by Rb+ or NH 4 + , and by veratridine. Electrical release and that induced by 50 mM K+ or 100µM veratridine was blocked by the omission of Ca2+ (with EDTA added) and that induced by veratridine was blocked by tetrodotoxin (30µM).

     
  5. 5.

    While Mg2+ and Mn2+ had little effect on electrical release of3H-DA, Li+ had a clearly inhibitory effect (IC50, ca. 0.3 mM).

     
  6. 6.

    Other monoamines induced significant efflux of3H-DA from unstimulated tissue, in descending rank order of effectiveness:p-tyramine > (+)-α-methyl-tyramine (p-hydroxyamphetamine) ⩾ (+)-amphetamine > (−)-amphetamine = 5-hydroxytryptamine (serotonin) = (±)-p-hydroxynorephedrine.

     
  7. 7.

    Other tritiated monoamines, previously accumulated at 0.3–0.7µM, were also released by electrical stimulation in the following descending rank order: (±)-octopamine ⩾ tyramine ⩾ (±)-norepinephrine = dopamine = (±)-metaraminol = (±)-α-methyltryamine » (±)-normetanephrine = 3-methoxytyramine.

     
  8. 8.

    Electrical release of3H-DA was largely unaffected by reserpine pretreatment [in the presence of a monamine oxidase (MAO) inhibitor]; release of tritiated tyramine, metaraminol, norepinephrine, and especially octopamine, was somewhat more reserpine sensitive.

     
  9. 9.

    These results indicate that3H-DA, previously accumulated by highaffinity uptake, can be released by electrical, ionic, or other depolarizing stimuli, and its efflux increased by monoamines [such as (+)-amphetamine] that also compete for uptake. Depolarization-induced release was highly calcium dependent, was inhibited by tetrodotoxin, and was strongly inhibited by lithium. Severalp-hydroxy analogues of DA or amphetamine (but not their 3-methoxy congeners) also were released by electrical-field stimulation, suggesting that they may be able to act as alternative or “false” transmitters in DA nerve terminals of the mammalian brain.

     

Key words

amphetamines dopamine false transmitters lithium release striatum 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arbilla, S., and Langer, S. Z. (1980). Influence of monoamine oxidase inhibition on the release of3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum.Naunyn-Schmiedeberg Arch. Pharmacol. 31145–52.Google Scholar
  2. Ary, T. E., and Komiskey, H. L. (1982). Phenyldidine-induced release of [3H]dopamine from chopped striatal tissue.Neuropharmacology 21639–645.Google Scholar
  3. Axelrod, J. (1954). Studies on sympathomimetic amines II. The biotransformation and physiological disposition of d-amphetamine, d-p-hydroxyamphetamine, and d-methamphetamine.J. Pharmacol. Exp. Ther. 110315–326.Google Scholar
  4. Baldessarini, R. J. (1971). Release of aromatic amines from brain tissue of the ratin vitro.J. Neurochem. 182509–2518.Google Scholar
  5. Baldessarini, R. J. (1975). Release of catecholamines. InHandbook of Psychopharmacology, Vol. 2 (L. L. Iversen, S. D. Iversen, and S. H. Synder, Eds.), Plenum Press, New York, pp. 37–137.Google Scholar
  6. Baldessarini, R. J., and Kopin, I. J. (1966). Tritiated norepinephrine: Release from brain slices by electrical stimulation.Science 1561630–1631.Google Scholar
  7. Baldessarini, R. J., and Kopin, I. J. (1967). The effect of drugs on the release of norepinephrine-3H from central nervous system tissues by electrical stimulationin vitro.J. Pharmacol. Exp. Ther. 15631–38.Google Scholar
  8. Baldessarini, R. J., and Vogt, M. (1971). The uptake and subcellular distribution of aromatic amines in the brain of the rat.J. Neurochem. 182519–2533.Google Scholar
  9. Baldessarini, R. J., and Vogt, M. (1972). Regional release of aromatic amines from tissues of the rat brainin vitro.J. Neurochem. 19755–766.Google Scholar
  10. Caviness, J. N., and Wightman, R. M. (1982). Use of rapid superfusion to differentiate the release of dopamine from striatal tissue induced by sympathomimetic amines from release induced by potassium.J. Pharmacol. Exp. Ther. 22390–96.Google Scholar
  11. Chesselet, M.-F., Cheramy, A., Reinsine, T., Lubetzki, C., and Glowinski, J. (1982). Presynaptic regulation of striatal dopamine release:In vitro studies.J. Physiol. Paris 78420–425.Google Scholar
  12. Cubeddu, L. X., Hofmann, I. S., and Paris, V. B. (1979). Effects of papaverine on the release and metabolism of dopamine in rat striatum.J. Pharmacol. Exp. Ther. 20973–78.Google Scholar
  13. DeBelleroche, J. S., and Neal, J. S. (1982). The contrasting effects of neuroleptics on transmitter release from nucleus accumbens and corpus straitum.Neuropharmacology 21529–537.Google Scholar
  14. Dismukes, R. K., and Mulder, A. H. (1977). Effects of neuroleptics on release of3H-dopamine from slices of rat corpus striatum.Naunyn-Schmeideberg Arch. Pharmacol. 29723–29.Google Scholar
  15. Dorris, R. L. (1976). Release of3H-α-methyl-m-tyramine from rat striatum in vitro.Eur. J. Pharmacol. 35225–228.Google Scholar
  16. Farnebo, L.-O. (1971). Release of monoamines evoked by field stimulation.Acta Physiol. Scand. Suppl. 37119–52.Google Scholar
  17. Fischer, J. E., and Baldessarini, R. J. (1971). False neurotransmitters and hepatic failure.Lancet 275–80.Google Scholar
  18. Glowinski, J., and Baldessarini, R. J. (1966). The metabolism of norepinephrine in the central nervous system.Pharmacol. Rev. 181201–1238.Google Scholar
  19. Harris, J. E., and Baldessarini, R. J. (1973). Uptake of [3H]-catecholamines by homogenates of rat corpus striatum and cerebral cortex: Effects of amphetamine analogues.Neuropharmacology 12669–679.Google Scholar
  20. Kant, G. J., and Myerhoff, J. L. (1978). Release of endogenous norepinephrine and dopamine from rat brain regionsin vitro.Life Sci. 232111–2118.Google Scholar
  21. Katz, R. I., and Kopin, I. J. (1969). Release of norepinephrine-3H and serotonin-3H evoked from brain slices by electrical field stimulation—Calcium dependency and the effects of lithium, ouabain, and tetrodotoxin.Biochem. Pharmacol. 181935–1939.Google Scholar
  22. Langer, S. Z. (1981). Presynaptic regulation of the release of catecholamines.Pharmacol. Rev. 32337–362.Google Scholar
  23. Liang, N. Y., and Rutledge, C. O. (1982). Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine.Biochem. Pharmacol. 31983–992.Google Scholar
  24. Milner, J. D., and Wurtman, R. J. (1984). Release of endogenous dopamine from electrically stimulated slices of rat striatum.Brain Res. 301139–142.Google Scholar
  25. Starke, K., and Montel, H. (1973). Interaction between indomethacin, oxymetazoline and phentolamine on the release of [3H]noradrenaline from brain slices.J. Pharm. Pharmacol. 25758–759.Google Scholar
  26. Starke, K., Reimann, W., Zumstein, A., and Hertting, G. (1978). Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleusin vitro.Naunyn-Schmiedeberg Arch. Pharmacol. 30527–36.Google Scholar
  27. Starr, M. S. (1979). GABA-mediated potentiation of amine release from nigrostriatal dopamine neuronesin vitro.Eur. J. Pharmacol. 53215–226.Google Scholar
  28. Stoof, J. C., Liem, A. L., and Mulder, A. H. (1976). Release and receptor stimulating properties ofp-tyramine in rat brain.Arch. Int. Pharmacodyn. Ther. 22062–71.Google Scholar
  29. Thompson, J. M., Whitaker, J. R., and Joseph, J. A. (1981). [3H]Dopamine accumulation and release from striatal slices in young, mature, and senescent rats.Brain Res. 224436–440.Google Scholar
  30. Westfall, T. C., Besson, M.-J., Giorguieff, M.-F., and Glowinski, J. (1976). The role of presynaptic receptors in the release and synthesis of3H-dopamine by slices of rat striatum.Naunyn-Schmiedeberg Arch. Pharmacol. 292279–287.Google Scholar

Copyright information

© Plenum Publishing Corporation 1988

Authors and Affiliations

  • Ross J. Baldessarini
    • 1
  • Marcella Vogt
    • 1
  1. 1.Departments of Psychiatry and Neuroscience ProgramHarvard Medical School and the Mailman Research Center, McLean HospitalBelmontUSA

Personalised recommendations